Literature DB >> 641139

Increased fluidity of human platelet membranes during complement-mediated immune platelet injury.

S J Shattil, D B Cines, A D Schreiber.   

Abstract

Complement appears to be involved in the destruction of platelets in certain clinical disorders, such as quinidine purpura and post-transfusion purpura. In both disorders, the classical complement sequence is activated by antigen-antibody complexes. It has been suggested that the terminal components of the complement sequence insert into the hydrophobic core of cell surface membranes and that this process leads to cell lysis. Fluidity is a fundamental property of lipids within the membrane's hydrophobic core. To examine the interaction of complement with membranes, we investigated the effect of complement activation on the fluidity of human platelet membranes. Complement was fixed to platelets using a post-transfusion purpura antibody, and membrane lipid fluidity was assessed in terms of fluorescence anisotropy using two fluorescent probes, 1,6-diphenyl-1,3,5-hexatriene and 9-(12-anthroyl) stearic acid. Microviscosity, expressed in poise, was derived from the fluorescence anisotropy of 1,6-diphenyl-1,3,5-hexatriene.Post-transfusion purpura antibody plus complement made platelet membranes more fluid as evidenced by a 21% decrease in anisotropy and a 35% decrease in microviscosity of platelets at 37 degrees C, and this was associated with platelet lysis ((51)Cr release). Complement damage to platelets was accompanied by a 10-15% increase in DeltaE, the fusion activation energy for microviscosity, indicating that complement not only decreased membrane microviscosity but also made membrane lipids less ordered. These changes were consistent and rapid, with platelet lysis and the reduction in microviscosity being half-maximal by 6 min. They were prevented by inactivation of complement with heat or with EDTA, and they were not observed when C5-deficient plasma was used as the complement source. Qualitatively similar changes in platelet membrane fluidity were observed when complement was fixed to platelets by a quinidine-dependent anti-platelet antibody rather than by post-transfusion purpura antibody. Post-transfusion purpura antibody plus complement also decreased the microviscosity of isolated platelet membranes. Moreover, the lipids extracted from platelets lysed by complement had a 22% decrease in microviscosity (P < 0.01), with no associated changes in the amount of cholesterol relative to phospholipid or in the amounts of the various phospholipids. These studies demonstrate that lipids within the hydrophobic core of platelet membranes damaged by complement become more fluid, and this is associated with platelet lysis. These findings are consistent with the concept that the insertion of the terminal complement components into the platelet membrane bilayer perturbs lipid-lipid interactions within the membrane's hydrophobic core.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 641139      PMCID: PMC372570          DOI: 10.1172/JCI108969

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  44 in total

1.  Determination of cholesterol using o-phthalaldehyde.

Authors:  L L Rudel; M D Morris
Journal:  J Lipid Res       Date:  1973-05       Impact factor: 5.922

2.  Phosphorus assay in column chromatography.

Authors:  G R BARTLETT
Journal:  J Biol Chem       Date:  1959-03       Impact factor: 5.157

3.  A new method for the direct determination of serum cholesterol.

Authors:  A ZLATKIS; B ZAK; A J BOYLE
Journal:  J Lab Clin Med       Date:  1953-03

4.  Intracellular distribution of lipophilic fluorescent probes in mammalian cells.

Authors:  R E Pagano; K Ozato; J M Ruysschaert
Journal:  Biochim Biophys Acta       Date:  1977-03-17

5.  Histocompatibility antigens of human plasma. Localization to the HLD-3 lipoprotein fraction.

Authors:  R H Aster; B H Miskovich; G E Rodey
Journal:  Transplantation       Date:  1973-09       Impact factor: 4.939

6.  Immune lytic transformation: a state of irreversible damage generated as a result of the reaction of the eighth component in the guinea pig complement system.

Authors:  R L Stolfi
Journal:  J Immunol       Date:  1968-01       Impact factor: 5.422

7.  Difference in microviscosity induced by different cholesterol levels in the surface membrane lipid layer of normal lymphocytes and malignant lymphoma cells.

Authors:  M Shinitzky; M Inbar
Journal:  J Mol Biol       Date:  1974-01-05       Impact factor: 5.469

8.  Isolation and characterization of plasma membranes from human blood platelets.

Authors:  A J Barber; G A Jamieson
Journal:  J Biol Chem       Date:  1970-12-10       Impact factor: 5.157

9.  Hereditary C5 deficiency in man. III. Studies of hemostasis and platelet responses to zymosan.

Authors:  R T Breckenridge; S I Rosenfeld; K S Graff; J P Leddy
Journal:  J Immunol       Date:  1977-01       Impact factor: 5.422

10.  Pathways of fatty acid metabolism in human platelets.

Authors:  P Cohen; A Derksen; H Van den Bosch
Journal:  J Clin Invest       Date:  1970-01       Impact factor: 14.808

View more
  3 in total

1.  Inflammatory mediators released by complement-derived peptides.

Authors:  H Bult; A G Herman
Journal:  Agents Actions       Date:  1983-08

2.  Molecular order and fluidity of the plasma membrane of human platelets from time-resolved fluorescence depolarization.

Authors:  C R Mateo; M P Lillo; J González-Rodríguez; A U Acuña
Journal:  Eur Biophys J       Date:  1991       Impact factor: 1.733

3.  Effects of irradiation on the interaction of fluorescent probes with lymphocytes.

Authors:  J C Standefer; R E Anderson; M Wilder; J Martin
Journal:  Am J Pathol       Date:  1984-02       Impact factor: 4.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.